Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
… Linda E Lévesque, assistant professor of epidemiology1… Correspondence to: L
Lévesque linda.levesque{at}queensu.ca … Articles by Linda E Lévesque …
Lévesque linda.levesque{at}queensu.ca … Articles by Linda E Lévesque …
Thiazolidinediones and cardiovascular outcomes in older patients with diabetes
LL Lipscombe, T Gomes, LE Lévesque, JE Hux… - Jama, 2007 - jamanetwork.com
ContextThiazolidinediones (TZDs), used to treat type 2 diabetes, are associated with an
excess risk of congestive heart failure and possibly acute myocardial infarction. However, the …
excess risk of congestive heart failure and possibly acute myocardial infarction. However, the …
[HTML][HTML] Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations
…, AM Burden, M Mamdani, LE Lévesque… - Journal of clinical …, 2015 - Elsevier
Objectives To describe the use and reporting of interrupted time series methods in drug
utilization research. Study Design and Setting We completed a systematic search of MEDLINE, …
utilization research. Study Design and Setting We completed a systematic search of MEDLINE, …
Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: a population-based, nested case-control analysis
V Schneider, LE Lévesque, B Zhang… - American Journal of …, 2006 - academic.oup.com
Conventional nonsteroidal antiinflammatory drugs (NSAIDs) are associated with acute renal
failure, but cyclooxygenase-2 inhibitors have not been comparatively evaluated. The …
failure, but cyclooxygenase-2 inhibitors have not been comparatively evaluated. The …
The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults
LE Lévesque, JM Brophy, B Zhang - Annals of Internal Medicine, 2005 - acpjournals.org
Background: Cyclooxygenase-2 (COX-2) selective inhibitors have been marketed since 1999
as safer alternatives to nonsteroidal anti-inflammatory drugs (NSAIDs). Debate about their …
as safer alternatives to nonsteroidal anti-inflammatory drugs (NSAIDs). Debate about their …
Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study
LM Smith, JS Kaufman, EC Strumpf, LE Lévesque - Cmaj, 2015 - Can Med Assoc
Background: Suboptimal human papillomavirus (HPV) vaccine coverage in some jurisdictions
is partly attributed to fears that vaccination may increase risky sexual behaviour. We …
is partly attributed to fears that vaccination may increase risky sexual behaviour. We …
Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive …
GBJ Mancini, M Etminan, B Zhang, LE Levesque… - Journal of the American …, 2006 - jacc.org
Objectives : The purpose of this study was to determine if statins (hydroxymethylglutaryl
CoA reductase inhibitors [HMG-CoA]), angiotensin-converting enzyme (ACE) inhibitors, and …
CoA reductase inhibitors [HMG-CoA]), angiotensin-converting enzyme (ACE) inhibitors, and …
The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts
BACKGROUND: Despite widespread promotion of quadrivalent human papillomavirus (qHPV)
vaccination for young girls, there is limited information on the vaccine’s real-world …
vaccination for young girls, there is limited information on the vaccine’s real-world …
Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy
…, G Carney, S Bugden, G Teare, LE Lévesque… - Cmaj, 2016 - Can Med Assoc
Background: Isotretinoin, a teratogen, is widely used to treat cystic acne. Although the risks of
pregnancy during isotretinoin therapy are well recognized, there are doubts about the level …
pregnancy during isotretinoin therapy are well recognized, there are doubts about the level …
Effectiveness of oral bisphosphonates in reducing fracture risk among oral glucocorticoid users: three matched cohort analyses
MA Amiche, LE Lévesque, T Gomes… - Journal of Bone and …, 2018 - academic.oup.com
The benefit of oral bisphosphonates in reducing fracture risk in glucocorticoid‐induced
osteoporosis is controversial. We aimed to estimate the effectiveness of oral bisphosphonates in …
osteoporosis is controversial. We aimed to estimate the effectiveness of oral bisphosphonates in …